![Feng Ming Liu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Feng Ming Liu
Algemeen Directeur bij Changzhou Biowin Pharmaceutical Co., Ltd.
Actieve functies van Feng Ming Liu
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Changzhou Biowin Pharmaceutical Co., Ltd.
![]() Changzhou Biowin Pharmaceutical Co., Ltd. Medical SpecialtiesHealth Technology Changzhou Biowin Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and distribution of point-of-care diagnostic test kits (POCT). Its products include vitro diagnostic tools, Chinese patents and related applications for treating heart disease, infectious diseases, stroke, kidney function, diabetes, cancer, and bone metabolism disorders. The company also operates research laboratory, technology platforms, and response system for the development of emergency-use diagnostic product. Changzhou Biowin Pharmaceutical was founded on November 22, 2011 and is headquartered in Changzhou, China. | Algemeen Directeur | 01-01-2012 | - |
Voorzitter | 01-01-2012 | - | |
Hoofd Techniek/Wetenschap/O&O | 01-01-2012 | - |
Loopbaan van Feng Ming Liu
Eerdere bekende functies van Feng Ming Liu
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
SHINECO, INC. | Algemeen Directeur | 03-08-2020 | - |
Hoofd Techniek/Wetenschap/O&O | 03-08-2020 | - |
Opleiding van Feng Ming Liu
Peking Union Medical College | Doctorate Degree |
Statistieken
Internationaal
China | 4 |
Operationeel
Chief Executive Officer | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Chairman | 1 |
Sectoraal
Process Industries | 2 |
Consumer Services | 2 |
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
SHINECO, INC. | Process Industries |
Bedrijven in privébezit | 1 |
---|---|
Changzhou Biowin Pharmaceutical Co., Ltd.
![]() Changzhou Biowin Pharmaceutical Co., Ltd. Medical SpecialtiesHealth Technology Changzhou Biowin Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and distribution of point-of-care diagnostic test kits (POCT). Its products include vitro diagnostic tools, Chinese patents and related applications for treating heart disease, infectious diseases, stroke, kidney function, diabetes, cancer, and bone metabolism disorders. The company also operates research laboratory, technology platforms, and response system for the development of emergency-use diagnostic product. Changzhou Biowin Pharmaceutical was founded on November 22, 2011 and is headquartered in Changzhou, China. | Health Technology |
- Beurs
- Insiders
- Feng Ming Liu
- Ervaring